Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    JournalClinical Pharmacology and Therapeutics
    Volume79
    Issue number3
    Pages (from-to)231-242
    Number of pages12
    ISSN0009-9236
    DOIs
    Publication statusPublished - 2006
    MoE publication typeA1 Journal article-refereed

    Cite this